Rang	Name	Position
1	Mr. Hadar Levy	Chief Executive Officer
2	Dr. David Zacut M.D.	Co-Founder & Vice-Chairman
3	Prof. Abraham Zangen Ph.D.	Co-Founder, Member of Scientific Advisory Board & Director
4	Mr. Ido Marom	Chief Financial Officer
5	Dr. Colleen Hanlon Ph.D.	Vice President of Medical Affairs
6	Mr. Michael Cohen	Vice President of US Sales
7	Dr. Yiftach Roth Ph.D.	Founder & Chief Scientific Officer
8	Mr. Dor Hagai	Vice President of Operations
9	Mr. Gilead Moiseyev Ph.D.	Chief Technology Officer
10	Mr. Menachem C. Klein Esq.	VP, General Counsel & Corporate Secretary

Aufteilung der Investoren

Rang	Inhaber	Anteile	Wert
1	Valor Management LLC	13,22%	74,04 Mio. USD
2	Masters Capital Management LLC	3,73%	20,90 Mio. USD
3	Acadian Asset Management LLC	2,04%	11,40 Mio. USD
4	Essex Investment Management Company, LLC	1,47%	8,26 Mio. USD
5	Renaissance Technologies Corp	1,29%	7,22 Mio. USD
6	Cresset Asset Management, LLC	0,78%	4,39 Mio. USD
7	Y.D. More Investments Ltd	0,68%	3,79 Mio. USD
8	SEI Investments Co	0,56%	3,15 Mio. USD
9	Legato Capital Management LLC	0,49%	2,75 Mio. USD
10	ARK Investment Management LLC	0,48%	2,70 Mio. USD
11	Eagle Global Advisors, LLC	0,45%	2,54 Mio. USD
12	The Goldman Sachs Group Inc	0,27%	1,50 Mio. USD
13	Morgan Stanley - Brokerage Accounts	0,26%	1,45 Mio. USD
14	Sigma Planning Corp	0,25%	1,40 Mio. USD
15	Two Sigma Investments LLC	0,25%	1,39 Mio. USD
16	Royce & Associates, LP	0,24%	1,35 Mio. USD
17	Huntleigh Advisors Inc	0,22%	1,22 Mio. USD
18	UBS Group AG	0,20%	1,14 Mio. USD
19	Trexquant Investment LP	0,19%	1,08 Mio. USD
20	Quadrature Capital Limited	0,16%	0,88 Mio. USD